News | News By Subject | News by Disease News By Date | Search News

Pain control News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
This Bay Area Biotech Snags $293 Million Pain Drug Pact With Novartis AG (NVS)     5/9/2017
For Sale: Nektar Therapeutics (NKTR) Plans to License Hot New Opioid Drug     3/21/2017
New Grunenthal CEO Forges Ahead with Treatment for Complex Regional Pain Syndrome     1/18/2017
Innocoll (INNL) Shares Tumble After FDA's Refusal to File Xaracoll NDA     12/30/2016
FDA Slaps Hold on Regeneron (REGN), Teva (TEVA)'s Pain Drug Fasinumab     10/18/2016
Gilead (GILD) Might Avoid Fighting Celgene (CELG), But Allergan (AGN), Intercept Pharma (ICPT) and Novartis AG (NVS) Await     10/4/2016
How Abbott (ABT) and Its Sales Reps Quietly Played a Role in the OxyContin Epidemic     9/22/2016
Teva (TEVA) Forges $2.6 Billion Deal to Buy Into Regeneron (REGN)'s Pain Drug Fasinumab     9/20/2016
Tonix Pharma (TNXP) to Stop Testing Lead Pain Drug, Stock Craters     9/6/2016
AcelRx (ACRX)' ARX-04 Phase 3 Trial Met its Primary Endpoint     8/15/2016
Endo International (ENDP) Withdraws Its Supplemental NDA for Pain Drug OPANA     8/12/2016
Recro Pharma (REPH) Shares Rocket as Intravenous Painkiller Succeeds in Phase III Trial     7/27/2016
What Purdue Pharma L.P. Knew About a Oxycontin Ring that Pushed More than 1 Million Pills     7/11/2016
Unclear Whether FDA Took Into Account KemPharm (KMPH)'s Amendment Data in Rejecting Apadaz Application     6/14/2016
Innocoll (INNL)'s Painkiller Passes Final Phase III Tests, Heads for 2017 Launch     5/25/2016

News from Around the Web
Why This Struggling Socal Biotech Could Be The Next Big Marijuana Stock     5/23/2017
3 Revolutionary Drugs for Chronic Pain     3/31/2017
Senators Question Kaleo Over 680% Price Hike of Naloxone Injector Evzio     2/10/2017
University of Pennsylvania Should Rethink Over-Hyped Press Releases     1/11/2017
Tech Devices To Treat Chronic Pain Could Curb Opioid Use, SPR Therapeutics Reveals     1/6/2017
New Compound May Treat Pain Without Opioid- Or Marijuana-Use Side Effects, Indiana University Study     11/15/2016
PRECISION Results Open The Door For OTC Celebrex     11/15/2016
Can A "Smart" Pain Management System Be Alternative To Opioids For Chronic Pain?     11/4/2016
Specialists Alarmed About Children Prescribed Opium-Derived Painkillers     10/31/2016
"Fake Pills" May Help Ease Back Pain, Beth Israel Deaconess Medical Center Study     10/21/2016
New Opioids Could Relieve Pain Without Dangerous Side Effects, UCSF Study     10/17/2016
Why Does My Pain Come And Go?     10/6/2016
An Opioid Spray Showered Billionaire John Kapoor In Riches. Now He's Feeling The Pain     10/5/2016
Artificial Knee Implant Provides New Treatment Options For Joint Pain     9/30/2016
For Pain Therapeutics (PTIE) CEO, 3 FDA Rejections Are Worth $23 Million     9/27/2016

Press Releases
Anika Therapeutics (ANIK) Announces Publication Of Phase III Data Demonstrating The Efficacy And Safety Of CINGAL For The Treatment Of Knee Pain Associated With Osteoarthritis     5/22/2017
NYU Langone Medical Center Release: Chronic Pain Amplifies The Brain's Reaction To New Injuries     5/22/2017
NeuroMetrix (NURO) Announces Issuance Of New U.S. Patent For Quell Wearable Pain Relief Technology     5/22/2017
Recro Pharma (REPH) Presents Phase III Bunionectomy Clinical Data For IV Meloxicam At The American Pain Society 36th Annual Scientific Meeting     5/18/2017
Exciting New Data For Intralink Spine’s Réjuve Treatment For Low Back Pain     5/16/2017
NeuroMetrix (NURO) Launches The Livingquell Blog, A New Platform For Exploring Perspectives On Chronic Pain     5/16/2017
SPR Therapeutics Awarded $6 Million Contract From The United States Department Of Defense To Advance Non-Opioid Pain Relief Therapy     5/15/2017
NeuroDigm Uses Tissue Repair In An Innovative Nerve Pain Model     5/12/2017
New Peer-Reviewed Clinical Study Successfully Validates The Use Of Proove Biosciences Opioid Risk To Predict Prescription Opioid Abuse     5/10/2017
Recro Pharma (REPH) Announces Successful Top-Line Results From Phase III Safety Study Of IV Meloxica     5/9/2017
tesa Labtec GmbH Offers New Licensing Opportunity: Ropivacaine Transdermal Patch For The Treatment Of Neuropathic Pain     5/9/2017
Mainstay Medical (MSTY.PA) Starts Commercialization Of ReActiv8 For The Treatment Of Chronic Low Back Pain In Ireland     5/9/2017
Turmoil Hits As TherapeuticsMD (TXMD)'s Vaginal Pain Drug Gets Rejected By The FDA     5/8/2017
Fidia Farmaceutici, S.p.A. Release: HYMOVIS: An Innovation In HA-Based Viscoelastic Hydrogel Technology In The Treatment Of Osteoarthritis Knee Pain     5/8/2017
BioDelivery (BDSI) Announces The Approval Of BUNAVAIL For Induction Of Buprenorphine Treatment For Opioid Dependence     5/2/2017